DBI — Deutsche Biotech Innovativ AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €4.78m
- €4.76m
Annual cashflow statement for Deutsche Biotech Innovativ AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.165 | -0.404 | -0.385 | -0.223 | -0.236 |
| Depreciation | |||||
| Non-Cash Items | -0.016 | 0.303 | 0.004 | 0.009 | 0.103 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.032 | 0.02 | -0.072 | -0.02 | 0.036 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.146 | -0.081 | -0.453 | -0.234 | -0.097 |
| Capital Expenditures | -0.002 | 0 | -0.008 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.002 | -0.1 | -0.3 | 0 | -0.004 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.1 | -0.308 | 0 | -0.004 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.15 | 0.15 | 0.675 | 0.225 | 0.09 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | -0.031 | -0.086 | -0.009 | -0.011 |